278 related articles for article (PubMed ID: 19010235)
21. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
[TBL] [Abstract][Full Text] [Related]
22. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
23. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
24. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
26. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
[TBL] [Abstract][Full Text] [Related]
27. Management of hepatocellular carcinoma recurrence after liver transplantation.
Valdivieso A; Bustamante J; Gastaca M; Uriarte JG; Ventoso A; Ruiz P; Fernandez JR; Pijoan I; Testillano M; Suarez MJ; Montejo M; Ortiz de Urbina J
Transplant Proc; 2010 Mar; 42(2):660-2. PubMed ID: 20304217
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
Kimura H; Yabushita K; Konishi K; Maeda K; Kuroda Y; Tsuji M; Demachi H; Miwa A
Int Surg; 1998; 83(2):146-9. PubMed ID: 9851333
[TBL] [Abstract][Full Text] [Related]
29. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report.
Sotiropoulos GC; Hilgard P; Antoch G; Nowak KM; Ertl J; Fouzas I; Molmenti EP; Sgourakis G; Beckebaum S; Paul A; Broelsch CE; Lang H
Transplant Proc; 2008 Dec; 40(10):3804-5. PubMed ID: 19100496
[TBL] [Abstract][Full Text] [Related]
31. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
Ataide EC; Boin IF; Almeida JR; Sevá-Pereira T; Stucchi RS; Cardoso AR; Caruy CA; Escanhoela CA
Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
[TBL] [Abstract][Full Text] [Related]
33. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
[TBL] [Abstract][Full Text] [Related]
34. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
[TBL] [Abstract][Full Text] [Related]
35. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
Rayya F; Harms J; Bartels M; Uhlmann D; Hauss J; Fangmann J
Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
[TBL] [Abstract][Full Text] [Related]
36. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation.
Park JW; Lee KW; Kim SJ; Choi SH; Heo JS; Kwon CH; Kim DJ; Han YS; Lee SK; Joh JW
Transplant Proc; 2006 Sep; 38(7):2121-2. PubMed ID: 16980018
[TBL] [Abstract][Full Text] [Related]
37. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
[TBL] [Abstract][Full Text] [Related]
38. HCC in living donor liver transplantation: can we expand the Milan criteria?
Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
[TBL] [Abstract][Full Text] [Related]
39. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
Seehofer D; Nebrig M; Denecke T; Kroencke T; Weichert W; Stockmann M; Somasundaram R; Schott E; Puhl G; Neuhaus P
Clin Transplant; 2012; 26(5):764-74. PubMed ID: 22432589
[TBL] [Abstract][Full Text] [Related]
40. Management of hepatocellular carcinoma in renal transplant recipients.
Chok KS; Lam CM; Li FK; Ng KK; Poon RT; Lo CM; Fan ST
J Surg Oncol; 2004 Sep; 87(3):139-42. PubMed ID: 15334642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
